Showing BioInteractions for Vayarin (DB09328)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
Interacting Group | Interacting Drugs | |
---|---|---|
Vayarin is a Fatty acid desaturase 1 substrate | ||
1 | Fatty acid desaturase 1 ligands | alpha-Linolenic acid, Evening primrose oil |
2 | Fatty acid desaturase 1 agonists | Icosapent |
3 | Fatty acid desaturase 1 substrates | Omega-6 fatty acids |
Interacting Group | Interacting Drugs | |
---|---|---|
Vayarin is a Elongation of very long chain fatty acids protein 4 substrate | ||
1 | Elongation of very long chain fatty acids protein 4 potentiators | Omega-3-carboxylic acids |
Interacting Group | Interacting Drugs | |
---|---|---|
Vayarin is a Peroxisomal acyl-coenzyme A oxidase 1 substrate |